Koshinski Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Koshinski Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-374	Closed	-$261K	–	1663
2022 Q1	$261K	Sell	374 -203	-35%	-$128K	0.02%	511
2021 Q4	$364K	Hold	577	–	–	0.03%	475
2021 Q3	$349K	Buy	+577	New	+$358K	0.03%	465
2021 Q2	–	Sell	-463	Closed	-$219K	–	605
2021 Q1	$219K	Sell	463 -80	-15%	-$39K	0.02%	546
2020 Q4	$262K	Hold	543	–	–	0.03%	463
2020 Q3	$327K	Sell	543 -80	-13%	-$48.5K	0.04%	381
2020 Q2	$389K	Buy	623 +65	+12%	+$36.9K	0.06%	329
2020 Q1	$272K	Buy	+558	New	+$230K	0.06%	359

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Koshinski Asset Management's REGN Position: Q2 2022 in Review

Koshinski Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2022, closing a stake of 374 shares — an estimated $261K sold.

Koshinski Asset Management first reported a position in REGN in Q1 2020 and held it in 8 quarters. The position peaked at $389K in Q2 2020. 1,064 funds tracked by Wall St. Rank hold REGN as of Q2 2022.

Koshinski Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Koshinski Asset Management sold 374 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $261K.
Koshinski Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 8 quarters.
Koshinski Asset Management's Regeneron Pharmaceuticals position peaked at $389K in Q2 2020.
1,064 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.